BARDA Funding for Next-Generation Therapeutics and Vaccines for COVID-19 available through Rapid Response Partnership Vehicle (RRPV) - EverGlade Consulting

BARDA Funding for Next-Generation Therapeutics and Vaccines for COVID-19 available through Rapid Response Partnership Vehicle (RRPV)

EverGlade and BARDA funding

The Rapid Response Partnership Vehicle (RRPV) Consortium is a joint initiative with the Biomedical Research and Development Authority (BARDA) to promote research and development in response to pandemics or public health emergencies. 

Scroll to Top
Flask with blue light

Webinar: R&D Funding in Life Sciences: What's Ahead in Trump 2.0?

Join us on Jan 15, 2025, at 12:00pm ET for a deep dive into the future of R&D Funding in Life Sciences.